
Despite promising results in an earlier trial, people taking the experimental drug intepirdine in the Phase III MINDSET trial did not see any substantial benefits in memory and thinking compared to those who took a placebo. These disappointing results feel like yet another setback, but Dr Clare Walton our Research Communications Manager explains why we should still be optimistic. […]